ArticleCureus2025
A Clinical Study to Evaluate Sensorineural Hearing Loss in Diabetic Patients Presenting to a Tertiary Healthcare Center.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hearing Health Monitoring in Adults Living with Diabetes: A Scoping Review to Inform Integrated Care Pathways.Audiology research · 2026Review
- Association of body mass index and cardiovascular risk profile with ménière's disease: A case-control study.Scientific reports · 2026Article
- Cardiovascular and sociodemographic factors associated with self-reported hearing loss: a cross-sectional analysis from the Polish PURE cohort.Archives of public health = Archives belges de sante publique · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Diabetes mellitus is a chronic disease that causes an array of dysfunctions, mainly because of its neuropathic and microvascular complications. This study was based on the hypothesis that these complications can lead to hearing loss in diabetic patients. The study also evaluates other influences on hearing loss in diabetic patients. Objectives The objective is to assess the prevalence of sensorineural hearing loss among diabetic patients and to analyze whether other factors contribute to worsening hearing loss among diabetics. Methods A prospective study was conducted among diabetic patients aged 35-60. A total of 86 patients were involved in this study. Results The prevalence of hearing loss among diabetic people in our study was 70.9%. Most hearing loss patients had mild sensorineural hearing loss, with a significant high-frequency slope or dip. There is a higher chance of hearing loss among diabetic patients if they have associated hypertension as well. No association between HbA1c level and duration of diabetes was established. As the age of the diabetic patient rises, there is a notable increase in the chance of having hearing loss as well, even though it was not statistically proven. Conclusions The hyperglycemic effects causing cochlear dysfunction start early in the phase of diabetes, and many people are unaware of their hearing deprivation. This might be because most of the affected people have mild sensorineural hearing loss. Early detection and intervention are needed to prevent the progression of this morbid condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.